{"id":"W4403992066","doi":"10.1016/j.lungcan.2024.108000","title":"Corrigendum to “Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK -positive advanced non-small cell lung cancer” [Lung Cancer 195 (2024) 107919]","year":2024,"lang":"en","type":"erratum","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency; Pfizer (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lung cancer; Tyrosine kinase; Cancer research; Tyrosine-kinase inhibitor; Cancer; Lung; Anaplastic lymphoma kinase; Oncology; Internal medicine; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003846362,0.001856174,0.002947516,0.00372528,0.002293281,0.00353749,0.002771416,0.007866053,0.07964113],"category_scores_gemma":[0.03873278,0.001257175,0.003233792,0.002569297,0.001185382,0.001379399,0.001437805,0.009652296,0.05579964],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006275434,"about_ca_system_score_gemma":0.007441358,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.07157055,"about_ca_topic_score_gemma":0.1262641,"domain_scores_codex":[0.995931,0.0006230056,0.0006522113,0.0005517002,0.001854273,0.0003879139],"domain_scores_gemma":[0.9797449,0.00604488,0.0008057212,0.0008436955,0.01154352,0.001017304],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001103602,0.000003581861,0.00002304088,0.00002109815,0.000004286526,0.00002905989,0.000001767663,0.0000171275,0.000006713364,0.00008565003,0.9983735,0.001423053],"study_design_scores_gemma":[0.000106524,0.00003612356,0.001821573,0.0003216708,0.00007641598,0.0001628809,0.00003216946,0.0003594451,0.0001453504,0.001218298,0.9956683,0.00005123413],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"other","genre_scores_codex":[0.00007706011,0.001249294,0.0002684102,0.09002363,0.8956915,0.00004822427,0.003163939,0.0002603772,0.009217616],"genre_scores_gemma":[0.00389196,0.006212356,0.002471567,0.2780015,0.2868808,0.0003700115,0.006977479,0.0007664456,0.4144279],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.07964113,"threshold_uncertainty_score":0.2664261,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01455766921570479,"score_gpt":0.3290218402154022,"score_spread":0.3144641709996974,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}